Alamar Biosciences, Inc.
corporate_fare Company Profile
Alamar Biosciences, Inc. (NASDAQ:ALMR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for ALMR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-11, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for ALMR spans 10-Q, 8-K, SCHEDULE 13D/A, SCHEDULE 13D.
Recent high-impact activity:
- Alamar Biosciences Surges 34% on Q2 Beat, Raised Guidance, and Alzheimer's Partnership Expansion
- Alamar Biosciences Reports Q2 Revenue of $29.4M (+82% YoY), Guides FY2026 Revenue to $116M–$120M
- Alamar Biosciences Delivers 82% Revenue Growth in Q2, Guides for 59% Full-Year Expansion
- Alamar Biosciences Expands Alzheimer's Partnership, Adding 86,000 Samples with New Neuro Panel
- Alamar Launches National Biomarker Initiative for Alzheimer's with Top Universities
Short Interest & Short Volume
7.95 days to coverFINRA reported short interest of 2,122,340 shares in ALMR as of the September 15, 2026 settlement, a 0.1% increase from the prior period — about 8.0 days to cover at its recent average daily volume. On October 2, 2026, 88.2% of ALMR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for ALMR, detected from its recent SEC filings · based on capital-structure filings through 2026-04-17.
Initial Public Offering Priced · Significant Capital Raise
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →